TrailBio® A9 Dopaminergic Neurons

TrailBio^® A9 Dopaminergic Neurons are highly characterized cells that resemble the A9 dopaminergic neuron state. These cells enable the screening of compounds that modulate the function and survival of A9 dopaminergic neurons, supporting drug development for neurological diseases such as Parkinson’s disease and other conditions involving dopaminergic neuron degeneration.

TrailBio^® A9 Dopaminergic Neurons are naturally differentiated from human iPSCs using the HD-DoE™ technology platform, meaning scalability is built-in.

Upon thawing, cells are ready for experimentation and express markers typical of A9 dopaminergic neurons. By simply maintaining cells in culture, they retain their characteristic dopaminergic neuron morphology and marker expression.